Thursday, March 28, 2013

Reuters: Health News: Pfizer gets new rebuff from UK cost body for cancer drug

Pfizer gets new rebuff from UK cost body for cancer drug

LONDON (Reuters) - Pfizer suffered a second rejection in two days from Britain's health cost watchdog NICE as its new kidney cancer drug Inlyta was tu...

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/MURu5tgxVBw/story01.htm


No comments:

Post a Comment

Subscribe Now: Feed Icon